Elanco Animal Health (ELAN) Tops Q4 EPS by 6c; Guides FY23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Elanco Animal Health Reports Fourth Quarter and Full Year 2022 Results
February 21, 2023 6:30 AM ESTFourth Quarter 2022 Financial Results: Revenue of $988 million Reported Net Loss of $54 million, Adjusted Net Income of $95 million Adjusted EBITDA of $174 million or 17.6% of Revenue Reported EPS of $(0.11), Adjusted EPS of $0.19 Net leverage ratio of 5.4x Adjusted EBITDA Full Year 2022 Financial Results: Revenue of $4,418 million Reported Net Loss of $74 million, Adjusted Net Income of $548 million Adjusted EBITDA of $1,023 million or 23.2% of Revenue Reported... More
